3beta-Androstanediol

CAS No. 571-20-0

3beta-Androstanediol( —— )

Catalog No. M22039 CAS No. 571-20-0

3beta-Androstanediol is an endogenous estrogen.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3beta-Androstanediol
  • Note
    Research use only, not for human use.
  • Brief Description
    3beta-Androstanediol is an endogenous estrogen.?
  • Description
    3beta-Androstanediol is an endogenous estrogen.?
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    571-20-0
  • Formula Weight
    292.46
  • Molecular Formula
    C19H32O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@@H](O)CC[C@]12C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.L H, Hoffman, N, Jahad, M C, Orgebin-Crist. The effects of testosterone, 5alpha-dihydrotestosterone, 3alpha-androstanediol, and 3beta-androstanediol on epithelial fine structure of the rabbit epididymis in organ culture.[J]. Cell & Tissue Research, 1976, 167(4):493-514.
molnova catalog
related products
  • IRL-1620 TFA (142569...

    IRL-1620 (TFA) is a potent selective endothelin receptor B (ETB) agonist with a Ki value of 16pm.

  • HA15

    HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.

  • Methenolone enanthat...

    Methenolone enanthate is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of anemia due to bone marrow failure.